- Home
- CEPU vs BCRX Comparison
CEPU vs BCRX Comparison
Compare CEPU & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEPU
- BCRX
- Stock Information
- Founded
- CEPU 1989
- BCRX 1986
- Country
- CEPU Argentina
- BCRX United States
- Employees
- CEPU N/A
- BCRX N/A
- Industry
- CEPU Electric Utilities: Central
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CEPU Utilities
- BCRX Health Care
- Exchange
- CEPU Nasdaq
- BCRX Nasdaq
- Market Cap
- CEPU 2.0B
- BCRX 1.7B
- IPO Year
- CEPU 2018
- BCRX 1994
- Fundamental
- Price
- CEPU $11.71
- BCRX $10.09
- Analyst Decision
- CEPU Hold
- BCRX Buy
- Analyst Count
- CEPU 1
- BCRX 8
- Target Price
- CEPU $12.00
- BCRX $16.75
- AVG Volume (30 Days)
- CEPU 275.2K
- BCRX 3.5M
- Earning Date
- CEPU 08-08-2025
- BCRX 08-04-2025
- Dividend Yield
- CEPU 2.62%
- BCRX N/A
- EPS Growth
- CEPU N/A
- BCRX N/A
- EPS
- CEPU 0.06
- BCRX N/A
- Revenue
- CEPU $697,204,690.00
- BCRX $503,485,000.00
- Revenue This Year
- CEPU $26.57
- BCRX $39.04
- Revenue Next Year
- CEPU N/A
- BCRX $13.26
- P/E Ratio
- CEPU $21.10
- BCRX N/A
- Revenue Growth
- CEPU N/A
- BCRX 41.67
- 52 Week Low
- CEPU $7.07
- BCRX $5.92
- 52 Week High
- CEPU $16.60
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- CEPU 42.41
- BCRX 43.54
- Support Level
- CEPU $11.68
- BCRX $9.84
- Resistance Level
- CEPU $12.52
- BCRX $10.47
- Average True Range (ATR)
- CEPU 0.53
- BCRX 0.34
- MACD
- CEPU -0.14
- BCRX -0.19
- Stochastic Oscillator
- CEPU 2.08
- BCRX 8.16
About CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.